Picture of Zai Lab logo

ZLAB — Zai Lab News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapHigh Flyer

Zai Lab's HK shares post record jump on positive data from partner's cancer therapy

** Hong Kong-listed shares of Chinese biopharma group Zai
Lab Ltd  9688.HK  soar as much as 46.8% to HK$40, their biggest
daily pct rise since debut in September 2020
    ** Stock tracks a 41.8% jump in U.S.-listed shares  ZLAB.O 
on Thursday, on positive data from a late-stage study of cancer
therapy by partner Novocure  NVCR.O   urn:newsml:reuters.com:*:nL4N33Q2MU
    ** Hong Kong shares hit the highest since Sept 15; biggest
pct gainer in Hang Seng Composite Index  .HSCI  and on the Hong
Kong bourse
    ** Shanghai-based company said on Friday it obtained an
exclusive license from NovoCure to develop and commercialize
Tumor Treating Fields in mainland China, Hong Kong Macau and
Taiwan
    ** The Hang Seng Commerce & Industry Index  .HSNC  gains
0.2% and the healthcare index  .HSCIH  rises 0.5%
    ** The Hang Seng Composite Index  .HSCI  climbs 0.3% and the
Hang Seng Index  .HSI  up 0.2%
 (Reporting by Donny Kwok)
 ((donny.kwok@thomsonreuters.com))

Recent news on Zai Lab

See all news